| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/21/2005 | US20050159415 Agents for preventing or ameliorating insulin resistance and /or obesity |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159361 Luteinizing hormone releasing hormone receptor agonist/antagonist (leuprorelin) and steroidal androgen receptor agonist (dehydroepiandrosterone, testosterone); sustained release |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050159336 Administering activated lymphocytes; promote nerve regeneration |
| 07/21/2005 | US20050159332 Ntb-a,a a surface molecule involved in natural killer cellss activity |
| 07/21/2005 | US20050159312 Biphenyl tertiary triamide is test substance as plant growth regulator; detecting if test substance reduces or blocks transcription, translation or expression of enzymes |
| 07/21/2005 | US20050158832 Secreted glycoprotein hormone fusion for use in regulating the level of red blood cells in circulation |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | US20050158771 Using gene expression patterns and skeletal muscle marker as diagnostic tool in detection and prognostication of obesity |
| 07/21/2005 | US20050158721 Using overexpression of senescence-associated genes as diagnostic/prognostic indicator of organ rejection/failure |
| 07/21/2005 | US20050158719 Polypeptide serving as angiogenic marker and dna thereof |
| 07/21/2005 | US20050158713 Fitness assay and associated methods |
| 07/21/2005 | US20050158709 Determining effect of human serum protein on viricidal agents; bioassay; enzyme inhibitors; plasma protein binding and drug efficacy; drug screening and pharmacokinetics |
| 07/21/2005 | US20050158409 Beverage with proanthocyanidins; protecting blood vessels |
| 07/21/2005 | US20050158406 Methods for treating joint inflammation |
| 07/21/2005 | US20050158393 Polymeric material associated with colloidal metal particles, especially gold, suitable for injection or implantation |
| 07/21/2005 | US20050158360 From a two-layered polymeric matrix including incompatible polymers, the top layer controls elution rate of said drugs; e.g. fluoropolymer layer covered with a polyacrylate top layer; stents, anastomotic devices |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158314 For treating chronic immune system disorders, inhibiting rejection of transplanted tissue |
| 07/21/2005 | US20050158291 Pet food composition for skin photoprotection |
| 07/21/2005 | US20050158290 Process for the preparation of a nutrient formulation |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | US20050158244 Cell population from staining a neoplastic cell population with a first marker, staining a dendritic cell population with a second marker, fusing the cells to obtain hybrid cell population stained with both markers; purifying |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2551896A1 Formulations of hydrophobic proteins in an immunogenic composition having improved tolerability |
| 07/20/2005 | EP1555263A1 Process for producing paroxetine hydrochloride hydrate |
| 07/20/2005 | EP1555030A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 07/20/2005 | EP1555028A1 Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy |
| 07/20/2005 | EP1555025A2 Use of dehydroepiandrosterone analogs for the treatment of asthma |
| 07/20/2005 | EP1555021A1 Combinations of a mevalonate pathway inhibitor and a PPAR-gamma agonist for treating cancer |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554393A2 P27 prevents cellular migration |
| 07/20/2005 | EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
| 07/20/2005 | EP1554268A1 Pyrazole inhibitors of the transforming growth factor |
| 07/20/2005 | EP1554265A2 Compounds, compositions and methods |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1554244A1 1-heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 07/20/2005 | EP1553971A2 THERAPIES FOR RENAL FAILURE USING INTERFERON-b |
| 07/20/2005 | EP1553931A1 Compounds, compositions, and methods |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553920A1 Topical formulation for prevention and treatment of acne |
| 07/20/2005 | EP1553909A2 Quick dissolve compositions and tablets based thereon |
| 07/20/2005 | EP1553831A2 Process for screening fungitoxic compounds |
| 07/20/2005 | EP1472251B1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 07/20/2005 | EP1385852B1 Compounds and methods for inhibiting mrp1 |
| 07/20/2005 | EP1381606B1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 07/20/2005 | EP1379511B1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II |
| 07/20/2005 | EP1345605B1 THERMOFORMed SOLID PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF PERINDOPRIL |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1268396B1 Diphenyl ether compounds useful in therapy |
| 07/20/2005 | EP1263774B1 Gamma-secretase inhibitors |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1173408B1 Ppar-(gamma) agonists as agents for the treatment of type ii diabetes |
| 07/20/2005 | EP1153931B1 Shortened-chain polynucleotides and process for the preparation thereof |
| 07/20/2005 | EP1152757B1 Mmp inhibitors in connective tissue softening |
| 07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0784430B1 Method for reducing unwanted cellular adhesions |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642979A VEGF peptides and their use |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642975A Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 07/20/2005 | CN1642974A Tripeptides having a hydroxyproline ether of a substituted quinoline for the inhibition of NS3 (hepatitis C) |
| 07/20/2005 | CN1642973A A method for treating allergies |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642970A Process for producing triterpene derivative |
| 07/20/2005 | CN1642961A Aminomethyl-substituted thiazolobenzimidazole derivative |
| 07/20/2005 | CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants |
| 07/20/2005 | CN1642956A Dipyridodiazepinones as reverse transcriptase inhibitors |
| 07/20/2005 | CN1642954A Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 07/20/2005 | CN1642952A Micronized crystalline tiotropium bromide |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642945A Stable hydrate of a muscarinic receptor antagonist |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642941A 1-N-aminobenzimidazole derivatives |
| 07/20/2005 | CN1642939A Pyridinoylpiperidines as 5-HTLF agonists |
| 07/20/2005 | CN1642938A New compounds |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642927A Cyclic amides |
| 07/20/2005 | CN1642926A Crystalline parecoxib sodium |
| 07/20/2005 | CN1642922A Substituted indazoles with anti-cancer activity |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |